Protein-based antigen presentation platforms for nanoparticle vaccines
Abstract Modern vaccine design has sought a minimalization approach, moving to the isolation of antigens from pathogens that invoke a strong neutralizing immune response. This approach has created safer vaccines but may limit vaccine efficacy due to poor immunogenicity. To combat global diseases suc...
Enregistré dans:
Auteurs principaux: | Brian Nguyen, Niraj H. Tolia |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/48d7babf85fb43848b0cf587c51a6749 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action
par: Franz X. Heinz, et autres
Publié: (2021) -
A new generation needle- and adjuvant-free trivalent plague vaccine utilizing adenovirus-5 nanoparticle platform
par: Paul B. Kilgore, et autres
Publié: (2021) -
Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic
par: Samir Andrade Mendonça, et autres
Publié: (2021) -
Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants
par: Sonia Budroni, et autres
Publié: (2021) -
A cell-based in vitro assay for testing of immunological integrity of Tetanus toxoid vaccine antigen
par: Olga Ticha, et autres
Publié: (2021)